Slush 2026 Preview: Helsinki's November Summit Is Still Europe's Single Biggest VC Weekend
With 13,000+ attendees and 500+ LPs expected in Helsinki, Slush 2026 remains the gravity center of European venture deal-making.
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
With 13,000+ attendees and 500+ LPs expected in Helsinki, Slush 2026 remains the gravity center of European venture deal-making.
BDC Capital's life sciences venture fund bolsters Canadian therapeutics and medtech — an underrated pipeline for U.S. and EU follow-on rounds.
Jeito Capital's €1B Fund II cements the case that Europe can fund late-stage biopharma domestically, without exporting all growth-stage capital to the U.S.
Blackstone's opportunistic private credit fund is not VC, but its scale directly changes how venture-backed companies refinance, recapitalize, and exit.
Mega buyout funds like KKR's 2026 vehicle aren't traditional VC, but they materially influence late-stage startup exits and crossover rounds.
Alcatraz's April 2026 round reflects growing demand for privacy-aware biometric access systems in critical facilities.